Re Clinical Trial for Verdiperstat - BHV 3241

EUROPEAN MSA PATIENTS TAKE NOTE: Below are a few points about Biohaven’s clinical study plans for Verdiperstat (BHV3241/AZD3241) in the European Union:

• Expect around 25 sites in Germany, France, Austria, UK and Italy

• Trial enrollment in Europe is anticipated to begin Nov/Dec 2019

• To learn more about the trial in the meantime, more details are available at: and

• A list of participating clinical sites in the EU will become available on the websites in future: and